CLU and systemic sclerosis: Consistent with the immunohistochemical data, clusterin mRNA expression was reduced in fibrotic (IPF and SSc derived) compared with control lung fibroblasts (Fig. 3A), suggesting that this change in clusterin messenger may be fibrosis related.